Teva shares climb as third-quarter sales top estimates - MarketWatch
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares - TheStreet
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook | AlphaStreet
Teva's Copaxone Successors Are Still Far From Success | Ctech
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Teva Pharmaceutical Industries Limited 2023 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva CEO Richard Francis on Q2 earnings beat
Teva profit plummets, stock slides | Ctech
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceuticals on LinkedIn: #quarterlyresults #earnings #tevapharm
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Seasonal Chart | Equity Clock
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Revenue Growth
TEVA | Market Realist
TEVA: A Pharmaceutical Stock to Watch Right Now - See It Market
Teva, armed with 2 recent launches, raises revenue guidance
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Reports Second Quarter 2023 Financial Results
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
